SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Direxion Shares ETF Trust - Direxion Daily Semiconductor Bull 3X ETF

Direxion Daily Semiconductor Bull 3X Shares

The semiconductor sector is facing extreme volatility as investors rotate out of chip stocks amid concerns over rising Treasury yields and the sustainability of AI-related data center infrastructure spending. Market participants are split between those aggressively scalping the downside or rotating into defensive sectors and those accumulating shares in anticipation of a potential rebound ahead of major upcoming earnings.

Cipher Digital, Inc. operates as a Bitcoin mining ecosystem in the United States. The firm is developing a cryptocurrency business. The company was founded in 2021 and is headquartered in New York, NY.

Cipher Digital Inc.

Cipher Digital is experiencing significant volatility as investors weigh the potential of its high-performance computing data centers against regulatory uncertainty and a broader sector sell-off. Community sentiment is deeply divided, with many traders holding for long-term AI-driven growth while others express frustration over the stock's recent decoupling from Bitcoin's upward momentum.

SELLAS Life Sciences Group, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunotherapeutic for cancer indications. Its product pipeline includes galinpepimut-S. The company was founded by Angelos M. Stergiou on April 3, 2006 and is headquartered in New York, NY.

SELLAS Life Sciences Group Inc

Sellas Life Sciences is trending as investors anticipate the pivotal 80th clinical event from the REGAL Phase 3 trial, with retail sentiment heavily debating the reliability of recent reports regarding the trial's status. The community is focused on the potential for a curative AML treatment, with widespread speculation on a future buyout amidst positive broader sector news in the cancer vaccine space.

Direxion Shares ETF Trust - Direxion Daily S&P Biotech Bear 3X ETF

Direxion Daily S&P Biotech Bear 3X Shares

The biotech sector is experiencing significant volatility and price swings, leading to high-volume trading in leveraged ETFs like LABD as participants debate whether recent rallies are a sustained trend or a short-term trap. Community sentiment remains polarized, with many traders actively scalping and swinging the stock while others voice frustration over the instrument's decay and the broader market's resilience against bearish catalysts.

Direxion Shares ETF Trust - Direxion Daily Semiconductor Bear 3X ETF

Direxion Daily Semiconductor Bear 3X ETF

Semiconductor stocks face ongoing volatility as the community remains divided over the sustainability of the AI data center boom, with many traders utilizing the Direxion Daily Semiconductor Bear 3X ETF to capitalize on potential tech sector pullbacks or hedge against broader macroeconomic concerns.

CoreWeave, Inc. engages in the powers of the creation and delivery of the intelligence that drives innovation. It offers a solution used by organizations of all sizes that require sophisticated AI computing, from the largest of enterprises to small, well-funded start-ups. The company was founded by Michael Intrator, Brian Venturo, Peter Salanki, and Brannin McBee on September 21, 2017 and is headquartered in Livingston, NJ.

CoreWeave Inc. - Ordinary Shares - Class A

CoreWeave Inc

CoreWeave is facing significant selling pressure as investors react to broader sector volatility, rising interest rate concerns, and persistent debates over the company's high debt levels and capital expenditures. While bullish community members point to strong contract backlogs and compute demand, bearish sentiment has intensified due to concerns over management's insider selling and speculative comparisons to other infrastructure-heavy models.

Strategy, Inc. engages in the development of fixed-income instruments that provide investors varying degrees of economic exposure to bitcoin. It executes bitcoin acquisition, capital management, and capital markets strategies. The company was founded by Michael J. Saylor and Sanjeev K. Bansal on November 17, 1989, and is headquartered in Tysons Corner, VA.

Strategy Inc. - Ordinary Shares - Class A

Strategy

MicroStrategy is trending as investors weigh its potential for a short squeeze and price appreciation against concerns over share dilution following recent Bitcoin rallies. The community remains deeply divided, with bulls pointing to the stock's role as a leveraged Bitcoin proxy and bears warning of a possible value trap.

Bitcoin is the world's first decentralized cryptocurrency, created in 2009 by the pseudonymous Satoshi Nakamoto. It enables peer-to-peer electronic cash transactions without intermediaries like banks or governments, operating on a blockchain secured by Proof of Work mining and the SHA-256 cryptographic algorithm.   With a fixed supply cap of 21 million coins and programmatic halvings every four years that reduce miner rewards, Bitcoin is designed as a deflationary digital asset often called "digital gold." Its value stems from solving the double-spending problem without trusted intermediaries, creating the first truly scarce digital asset with censorship resistance and permissionless access that no government, corporation, or individual can control.  Bitcoin operates as a decentralized peer-to-peer network where transactions are recorded on a public ledger called the blockchain, distributed across thousands of computers globally. Transactions are grouped into blocks added approximately every 10 minutes through mining, where specialized computers compete to solve complex mathematical puzzles.   Bitcoin has achieved mainstream adoption through multiple vectors. The January 2024 SEC approval of 11 spot Bitcoin ETFs opened Bitcoin investment to traditional finance participants, and corporations like Strategy (formerly MicroStrategy) are using Bitcoin as a treasury reserve asset to protect against currency debasement, offering MSTR holders amplified exposure to Bitcoin.   The Bitcoin ecosystem continues to evolve with innovations like Ordinals, which emerged in January 2023 to enable NFT-like functionality directly on Bitcoin, and BRC-20 tokens, an experimental standard for creating fungible tokens using Ordinal inscriptions. BTCFi (Bitcoin Finance) represents emerging financial applications extending beyond Bitcoin's traditional role, with protocols like Babylon allowing Bitcoin holders to stake BTC to secure Proof of Stake chains.

Bitcoin

Bitcoin is seeing heavy discussion as traders debate whether current price levels signal a sustained breakout or a bull trap, with many closely watching key technical resistance levels. Community sentiment is sharply divided between bulls expecting further gains toward record highs and bears warning of potential liquidation risks and volatility ahead.

Tempus AI, Inc. is a healthcare technology company, which engages in bringing artificial intelligence and machine learning to healthcare. It focuses on building platforms for oncology, neuropsychiatry, cardiology, infectious disease, and radiology. The company was founded by Eric Paul Lefkofsky in August 2015 and is headquartered in Chicago, IL.

Tempus AI Inc. - Ordinary Shares - Class A

Tempus AI Inc

Tempus AI is trending as investors react to the company's $1.5 billion acquisition of Personalis, with community sentiment divided between the strategic long-term value of the combined genomic sequencing capabilities and skepticism regarding the deal's structure and dilution risks. Traders are actively monitoring potential short-squeeze activity, buoyed by the company's association with recent positive clinical results for personalized mRNA cancer vaccines.

Alibaba Group Holding Ltd. engages in providing technology infrastructure and marketing reach. It operates through the following business segments: China Commerce, International Commerce, Local Consumer Services, Cainiao, Cloud, Digital Media and Entertainment, and Innovation Initiatives and Others segments. The Core Commerce segment consists of platforms operating in retail and wholesale. The China Commerce segment includes China commerce retail and wholesale businesses. The International Commerce segment focuses on international commerce retail and wholesale businesses. The Local Consumer Services segment is involved in To-Home businesses, which include Ele.me, local services and delivery platform, and Taoxianda, and To-Destination segment businesses which include Amap, the provider of mobile digital map, navigation and real-time traffic information, and restaurant and local services guide platform. The Cainiao segment has Cainiao Network and offers domestic and international one-stop-shop logistics services and supply chain management solution. The Cloud segment includes Alibaba Cloud and DingTalk. The company was founded by Chung Tsai and Yun Ma on June 28, 1999 and is headquartered in Hangzhou, China.

Alibaba Group Holding Ltd - ADR

Alibaba Group Holding Ltd

Alibaba is trending due to concerns over shareholder dilution following a massive equity raise to fund AI infrastructure, a move that prompted high-profile investors like Michael Burry to exit their positions. Despite these bearish pressures, retail sentiment remains extremely bullish as traders focus on the company's cloud growth and potential for a sharp rebound ahead of upcoming earnings.

statis crypto Watchlist

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Avenue Therapeutics, Inc. is a specialty pharmaceutical company, which engages in acquiring, licensing, and commercializing products for use in the intensive care hospital setting. It focuses on the development of intravenous tramadol, a potential alternative that could reduce the use of conventional opioids for patients suffering from acute pain. The company was founded on February 9, 2015 and is headquartered in Bay Harbor Islands, FL.

Avenue Therapeutics Inc

Bearish Sentiment

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

Current Price	$0.2576
Prev Close	$0.2806
Open	$0.2806
Dividend Yield	0.00%
50-Day Moving Average	$0.2928
Beta	-0.05
Avg. Volume	3,270.05
PE Ratio	-0.30

52-Week High	$0.9699
52-Week Low	$0.15
Market Capitalization	$848,784.00
EPS (Annual)	-$0.9291
Price to Book	1.49
Revenue Per Employee	$1.4M

Feed

News

Sentiment

Fundamentals

Info